Neural stem cell transplant for chronic stroke survivors
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a single injection of neural stem cells into the brain can improve motor function in people who had a stroke at least 6 months ago. It is for adults aged 18 to 75 with moderate movement difficulties.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke caused by a blockage in the middle cerebral artery, confirmed by MRI or CT scan.
- Your stroke happened between 6 months and 7 years ago.
- You are between 18 and 75 years old.
- You still have significant arm or leg weakness from the stroke.
- Your stroke lesion is between 1 and 100 cubic centimeters on MRI.
- You are not taking blood thinners that cannot be stopped safely for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This trial tests whether umbilical cord stem cells given within a month after a stroke can help patients recover. It is for people with a moderate to moderately severe stroke affecting the front part of the brain.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
Hear when a new Chronic Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.